Igenomix
A global leader in women’s health and reproductive genetic testing services for IVF clinics.
The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries.
- Sector
Healthcare
- Country
Spain
- Fund
EQT VIIII
- Entry
2019
- Exit
2021
Responsible Advisor
Vesa Koskinen
Website
About Igenomix
Igenomix’s vision is to become the worldwide reference in reproductive medicine and women’s health. Over the last decade, the Company has positioned itself as an innovation leader, supported by world-class R&D, and has established a global footprint with a network of 19 labs across 16 countries. Igenomix has also developed a diversified portfolio of IVF genetic services covering all phases of the reproductive cycle: i) preconception, ii) pre-implantation; and iii) pre-natal. The Company is headquartered in Valencia, Spain and employs +390 people, of which c.18% hold a PhD and have contributed to +440 scientific publications.
Do You Want to Know More?
We are eager to explore how we can achieve great things together.